中文 | English
Return
Total: 7 , 1/1
Show Home Prev Next End page: GO
Author:(Fangzhao LIN)

1.Isolation and purification of human plasma coagulation Factor Ⅺ

Yuxiang HOU ; Fangzhao LIN ; Xiaopu XIAO

Chinese Journal of Blood Transfusion 2008;0(12):-

2.Isolation and purification of human coagulation factor Ⅶ from Cohn fraction Ⅲ paste

Shizhou XU ; Qingrong ZHAO ; Fangzhao LIN ; Ling XIAO ; Xiaopu XIAO ;

Chinese Journal of Blood Transfusion 2002;0(05):-

3.Tirofiban interferes with antibody-mediated transfusion-related acute lung injury by inhibiting platelet-neutrophil binding

Xin YUAN ; Yunhong YU ; Congchao QIAO ; Pan SUN ; Na SU ; Peng JIANG ; Fangzhao LIN

Chinese Journal of Blood Transfusion 2022;35(4):377-382

4.Potential of modulating fibrinolytic activity in intervention of transfusion-related acute lung injury

Yunhong YU ; Peng JIANG ; Pan SUN ; Na SU ; Xin YUAN ; Fangzhao LIN

Chinese Journal of Blood Transfusion 2021;34(8):922-925

5.Activation of death receptor 3 signaling pathway prevents antibody-mediated transfusion-related acute lung injury via αDR3 antibody

Yunhong YU ; Xin YUAN ; Pan SUN ; Na SU ; Peng JIANG ; Fangzhao LIN

Chinese Journal of Blood Transfusion 2021;34(5):435-440

6.Efficacy analysis of von Willebrand factor in human coagulation factor FⅧ concentrates in China

Xi DU ; Li MA ; Zongkui WANG ; Shengliang YE ; Fengjuan LIU ; Rong ZHANG ; Na SU ; Fangzhao LIN ; Haijun CAO ; Changqing LI

Chinese Journal of Blood Transfusion 2021;34(6):574-578

7.Desalination effect on FⅧ components: a compartive study among 5 desalination methods

Renjun PEI ; Xi DU ; Pan SUN ; Xiaoyue LI ; Peng JIANG ; Changqing LI ; Fangzhao LIN ; Haijun CAO

Chinese Journal of Blood Transfusion 2024;37(3):304-311

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 7 , 1/1 Show Home Prev Next End page: GO